Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carmen Couto
Institutions:
Hospital Universitario de Valme,
Universidad de Sevilla
Observed institutions:
Hospital Universitario de Valme,
Universidad de Sevilla
OpenAlex ID:
A5038950065
Association of NOS3 gene with metabolic syndrome in hypertensive patients
2004
·
Maria Fernandez
, Rocio Ruiz
, et al.
·
Thrombosis and Haemostasis
·
60
Genetic analysis of CAV1 gene in hypertension and metabolic syndrome
2006
·
Antonio Grilo
, Maria Fernandez
, et al.
·
Thrombosis and Haemostasis
·
26
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma
2024
·
Marta Lasa
, Laura Notarfranchi
, et al.
·
Journal of Clinical Oncology
·
20
Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation
2017
·
Felipe de Arriba de la Fuente
, Maria Soledad Durán
, et al.
·
Seminars in Hematology
·
8
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study
2026
·
José Vicente Gil
, Claudia Sargas
, et al.
·
Haematologica
·
2
Ending the undetermined significance of monoclonal gammopathies (MGUS): First results of the nomoremgus study
2025
·
Marta Lasa
, Esperanza Martin-Sanchez
, et al.
·
Blood
·
1
PDF
Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy
2026
·
Bruno Paiva
, Leire Burgos
, et al.
·
Leukemia
Real‐World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3 ‐Mutated AML: The PETHRATIFY Study
2026
·
Mónica Alejandra Romero Riquelme
, Gaspar Aspas Requena
, et al.
·
American Journal of Hematology
PDF
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group
2026
·
Rafael Colmenares
, Eva Barragán
, et al.
·
Bone Marrow Transplantation
PDF
Validation of ELN 2024 genetic classification in patients with AML treated with HMA-based regimens: PETHEMA registry study
2026
·
Eva Barragán
, José Vicente Gil
, et al.
·
Blood Neoplasia
Measurable residual disease (MRD) assessment as an early end point oftreatment efficacy in acute myeloid leukemia (AML): A pethema studyof 2,623 patients (Pts) treated with intensive therapy
2025
·
Bruno Paiva
, Leire Burgos
, et al.
·
Blood
PDF
Clinical Features and Treatment in Patients Diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm: Interim Analysis from the Pethema Epidemiologic Registry (EPI-BLAS study)
2023
·
Irene Navarro Vicente
, Pilar Lloret Madrid
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
12
Citation count:
117
H-index:
4
I10-index:
3
Year
Topic
Type